IP Group PLC Investor webinar

TIDMIPO

IP Group PLC

21 October 2020

 
 FOR RELEASE ON   21 October 2020 
 

IP Group - Investor webinar

IP Group plc (LSE: IPO) ("IP Group" or "the Company" or "the Group"), the developer of intellectual property-based businesses, is pleased to announce that it will be hosting a webinar on the role that science and innovation has to play in building resilience in health systems.

The webinar, which will take place on Thursday 29 October at 16:00GMT, will feature short presentations from Dr Gordon Sanghera, CEO of portfolio company Oxford Nanopore Technologies, and Hugh Lloyd-Jukes, CEO of portfolio company Oxehealth, detailing how their companies have innovated in the battle against the pandemic.

IP Group is committed to clear and open communication with stakeholders and attendees will have the opportunity to ask questions as part of the event. For more details or to register as a participant please visit https://www.ipgroupplc.com/events .

No material new information will be released by the Company during the webinar.

For more information, please contact:

 
 IP Group plc                            www.ipgroupplc.com 
                                         [phone] 
 Alan Aubrey, Chief Executive Officer 
  Greg Smith, Chief Financial Officer     [phone]/+44 (0) 
  Liz Vaughan-Adams, Communications       7979 853802 
 Charlotte Street Partners 
 David Gaffney                           [phone] 
 Andrew Wilson                           [phone] 
 

Notes for editors

About IP Group

IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

For more information, please visit our website at www.ipgroupplc.com .

ENDS

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NRAPPGQCUUPUGCU

(END) Dow Jones Newswires

October 21, 2020 02:00 ET (06:00 GMT)